Description

AQUAZIDE 25 MG

Indications

AQUAZIDE 25 MG is primarily indicated for the management of hypertension and edema associated with congestive heart failure, liver cirrhosis, and renal disorders. It is commonly prescribed to patients who require diuretic therapy to help reduce fluid retention and lower blood pressure. The active ingredient in AQUAZIDE is hydrochlorothiazide, which is a thiazide diuretic that promotes diuresis (increased urine production) and helps to manage fluid balance in the body.

Mechanism of Action

The mechanism of action of AQUAZIDE involves the inhibition of sodium reabsorption at the distal convoluted tubule in the nephron of the kidney. By blocking the sodium-chloride symporter, hydrochlorothiazide prevents the reabsorption of sodium and chloride ions back into the bloodstream. This leads to increased excretion of sodium and water, resulting in a reduction of blood volume and a subsequent decrease in blood pressure. Additionally, the diuretic effect helps to alleviate edema by promoting fluid loss from the tissues.

Pharmacological Properties

AQUAZIDE has several pharmacological properties that contribute to its therapeutic effects. It is classified as a thiazide diuretic and exhibits a moderate diuretic effect, which is dose-dependent. The onset of action typically occurs within 1 to 2 hours after oral administration, with peak effects observed between 4 to 6 hours. The duration of action lasts for approximately 6 to 12 hours. Hydrochlorothiazide is absorbed well from the gastrointestinal tract, and its bioavailability is approximately 60-80%. It is primarily excreted unchanged in the urine.

Contraindications

AQUAZIDE should not be used in patients with a known hypersensitivity to hydrochlorothiazide or any of its components. It is also contraindicated in individuals with anuria (the absence of urine production), severe renal impairment, and electrolyte imbalances such as hypokalemia or hyponatremia. Caution should be exercised when prescribing AQUAZIDE to patients with a history of gout, as it may exacerbate hyperuricemia. Pregnant and breastfeeding women should consult their healthcare provider before using this medication.

Side Effects

Common side effects associated with AQUAZIDE include dizziness, headache, and gastrointestinal disturbances such as nausea and diarrhea. More serious side effects may occur, including electrolyte imbalances (hypokalemia, hyponatremia), dehydration, and hypotension. Patients should be monitored for signs of these adverse effects, particularly those with pre-existing conditions that may be exacerbated by diuretic therapy. Rarely, hypersensitivity reactions such as rash, itching, or anaphylaxis may occur.

Dosage and Administration

The recommended starting dose of AQUAZIDE for adults is typically 25 mg once daily. Depending on the patient’s response and clinical condition, the dosage may be adjusted. In some cases, a maximum dose of 50 mg per day may be prescribed. It is important for patients to take AQUAZIDE in the morning to avoid nocturia (frequent urination at night). The medication can be taken with or without food, but it is advisable to maintain consistent timing for optimal results.

Interactions

AQUAZIDE may interact with other medications, which can affect its efficacy or increase the risk of side effects. Notable interactions include non-steroidal anti-inflammatory drugs (NSAIDs), which may reduce the diuretic effect of hydrochlorothiazide. Additionally, the use of AQUAZIDE with other antihypertensive agents may lead to additive hypotensive effects. Patients taking potassium-sparing diuretics or supplements should be monitored closely, as AQUAZIDE can cause electrolyte disturbances. It is essential for patients to inform their healthcare provider about all medications and supplements they are currently taking.

Precautions

Patients with a history of renal or hepatic impairment should use AQUAZIDE with caution, as these conditions may affect the drug’s clearance and increase the risk of adverse effects. Regular monitoring of renal function and electrolyte levels is recommended during treatment. Elderly patients may be more susceptible to the side effects of AQUAZIDE, particularly hypotension and electrolyte imbalances. It is also important to assess the patient’s overall health status, including any existing medical conditions, before initiating therapy.

Clinical Studies

Clinical studies have demonstrated the efficacy of AQUAZIDE in lowering blood pressure and managing edema. In a randomized controlled trial, patients treated with hydrochlorothiazide showed significant reductions in systolic and diastolic blood pressure compared to placebo. Furthermore, studies have indicated that AQUAZIDE effectively reduces fluid retention in patients with congestive heart failure and other conditions associated with edema. Long-term studies have also suggested that thiazide diuretics, including AQUAZIDE, may provide cardiovascular protection in hypertensive patients.

Conclusion

AQUAZIDE 25 MG is a valuable therapeutic option for the management of hypertension and edema. Its mechanism of action as a thiazide diuretic facilitates the excretion of excess fluid and sodium, thereby helping to control blood pressure and alleviate symptoms associated with fluid retention. While generally well-tolerated, it is important for patients to be aware of potential side effects and drug interactions. Regular monitoring and communication with healthcare providers are essential to ensure safe and effective use of AQUAZIDE.